Ana Laus to Carcinoma, Squamous Cell
This is a "connection" page, showing publications Ana Laus has written about Carcinoma, Squamous Cell.
Connection Strength
1.501
-
Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, Martin ACBM, do Nascimento Braga Pereira L, de Carvalho CEB, Crovador CS, de Paula FE, Nascimento FC, de Freitas HT, de Lima Vazquez V, Reis RM, da Silva-Oliveira RJ. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024 Jul; 37(4):1170-1183.
Score: 0.738
-
Laus AC, da Silva IDCG, Cordeiro FB, Lo Turco EG, de Souza Viana L, Carvalho AL. Is Lipidomic the Answer to the Search of a Biomarker for Organ Preservation Protocol in Head and Neck Squamous Cell Carcinoma? Pathol Oncol Res. 2018 Oct; 24(4):931-935.
Score: 0.474
-
Cousseau CPV, Sorroche BP, de Jesus Teixeira R, de Carvalho AC, Melendez ME, de Castro Capuzzo R, Laus AC, da Silva LS, de Menezes NS, Carvalho AL, Arantes LMRB. miR-99a-5p as a biomarker for lymph node metastasis prediction in oral squamous cell carcinoma patients. Head Neck. 2023 10; 45(10):2489-2497.
Score: 0.176
-
Arantes LM, Laus AC, Melendez ME, de Carvalho AC, Sorroche BP, De Marchi PR, Evangelista AF, Scapulatempo-Neto C, de Souza Viana L, Carvalho AL. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol. Oncotarget. 2017 Feb 07; 8(6):9911-9921.
Score: 0.112